Combining the sustainable culture of billions of human cells and the bioprinting of wholly cellular bioinks offers a pathway toward organ‐scale tissue engineering. Traditional 2D culture methods are not inherently scalable due to cost, space, and handling constraints. Here, the suspension culture of human induced pluripotent stem cell‐derived aggregates (hAs) is optimized using an automated 250 mL stirred tank bioreactor system. Cell yield, aggregate morphology, and pluripotency marker expression are maintained over three serial passages in two distinct cell lines. Furthermore, it is demonstrated that the same optimized parameters can be scaled to an automated 1 L stirred tank bioreactor system. This 4‐day culture results in a 16.6‐ to 20.4‐fold expansion of cells, generating approximately 4 billion cells per vessel, while maintaining >94% expression of pluripotency markers. The pluripotent aggregates can be subsequently differentiated into derivatives of the three germ layers, including cardiac aggregates, and vascular, cortical and intestinal organoids. Finally, the aggregates are compacted into a wholly cellular bioink for rheological characterization and 3D bioprinting. The printed hAs are subsequently differentiated into neuronal and vascular tissue. This work demonstrates an optimized suspension culture‐to‐3D bioprinting pipeline that enables a sustainable approach to billion cell‐scale organ engineering.
Direct ink writing is compatible with an expansive materials palette. While enabling diverse applications, this materials versatility brings significant bottlenecks in ink formulation, often requiring the mixing, printing, and testing of dozens to hundreds of ink compositions over the course of a project. To accelerate ink-space exploration, we introduce gradient embedded multinozzle (GEM) printheads that combine the high-throughput parallelized printing of multinozzles with combinatorial ink mixing. These printheads allow simultaneous mixing of two-, three-, and four-input inks which are distributed to printer nozzles to create complex 3D structures with graded compositions of inks. Using a two-way GEM printhead, we vali-date cell compatibility by printing scaffolds containing various concentrations of fibroblasts and observing non-linear compaction behaviours. We next test a three-way GEM multinozzle to print ten compositions of di- and multi-functionalized poly(ethylene-glycol) diacrylate hydrogel tri-leaflet valves, optimizing for stiffness, swelling ratio, and toughness. Our GEM multinozzles are compatible with open-source printers and either pressure- or volume-driven extrusion systems and promise to accelerate iterative ink design and testing.
Complex patient-specific bone defects remain difficult to reconstruct because the regenerative capacity of bone is limited and prefabricated implants cannot readily match defect geometry. In this work, methylcellulose-gelatin-hydroxyapatite (MC/GEL/HA) inks were formulated with varying methylcellulose content and hydroxyapatite incorporation, crosslinked with EDC/NHS, and 3D-printed into porous scaffolds with defined square-pore architectures. Inks were evaluated by oscillatory and steady-shear rheology, and printed scaffolds were characterized for morphology, chemical composition, mechanical performance, physicochemical stability, wettability, apatite-forming bioactivity, and osteogenic responses of human bone marrow mesenchymal stem cells. Methylcellulose content primarily governed ink rheology and printability, and increased compressive strength (up to ~0.38 MPa for 15MC/10GEL/30HA), whereas hydroxyapatite enhanced surface hydrophilicity, promoted apatite nucleation within 7 days in simulated body fluid, and markedly increased alkaline phosphatase activity (>10-fold over HA-free scaffolds), mineralization (~2-fold by Alizarin Red), and the highest osteocalcin expression among the HA-containing formulations (~2.45-fold at day 14). The 15MC/10GEL/30HA formulation showed the most favorable balance of printability, mechanical performance, and osteogenic performance. These complementary functions reconciled structural stability with osteogenic performance, supporting the MC/GEL/HA system as a tunable bioink platform for non-weight-bearing bone regeneration, while warranting further in vivo validation.